Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Oct;38(10):2231–2237. doi: 10.1128/aac.38.10.2231

Antimicrobial susceptibility of coagulase-negative staphylococci.

G L Archer 1, M W Climo 1
PMCID: PMC284723  PMID: 7840550

Full text

PDF
2234

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldridge K. E., Schiro D. D., Varner L. M. In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods. Antimicrob Agents Chemother. 1992 Apr;36(4):854–855. doi: 10.1128/aac.36.4.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Archer G. L. Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices. Antimicrob Agents Chemother. 1978 Sep;14(3):353–359. doi: 10.1128/aac.14.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Archer G. L., Armstrong B. C. Alteration of staphylococcal flora in cardiac surgery patients receiving antibiotic prophylaxis. J Infect Dis. 1983 Apr;147(4):642–649. doi: 10.1093/infdis/147.4.642. [DOI] [PubMed] [Google Scholar]
  4. Archer G. L., Auger P., Doern G. V., Ferraro M. J., Fuchs P. C., Jorgensen J. H., Low D. E., Murray P. R., Reller L. B., Stratton C. W. RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis. 1993 Mar-Apr;16(3):223–226. doi: 10.1016/0732-8893(93)90113-l. [DOI] [PubMed] [Google Scholar]
  5. Archer G. L., Coughter J. P., Johnston J. L. Plasmid-encoded trimethoprim resistance in staphylococci. Antimicrob Agents Chemother. 1986 May;29(5):733–740. doi: 10.1128/aac.29.5.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Archer G. L., Johnston J. L. Self-transmissible plasmids in staphylococci that encode resistance to aminoglycosides. Antimicrob Agents Chemother. 1983 Jul;24(1):70–77. doi: 10.1128/aac.24.1.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Archer G. L., Johnston J. L., Vazquez G. J., Haywood H. B., 3rd Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies. Rev Infect Dis. 1983 Jul-Aug;5 (Suppl 3):S538–S542. doi: 10.1093/clinids/5.supplement_3.s538. [DOI] [PubMed] [Google Scholar]
  8. Archer G. L., Karchmer A. W., Vishniavsky N., Johnston J. L. Plasmid-pattern analysis for the differentiation of infecting from noninfecting Staphylococcus epidermidis. J Infect Dis. 1984 Jun;149(6):913–920. doi: 10.1093/infdis/149.6.913. [DOI] [PubMed] [Google Scholar]
  9. Archer G. L., Pennell E. Detection of methicillin resistance in staphylococci by using a DNA probe. Antimicrob Agents Chemother. 1990 Sep;34(9):1720–1724. doi: 10.1128/aac.34.9.1720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Archer G. L., Scott J. Conjugative transfer genes in staphylococcal isolates from the United States. Antimicrob Agents Chemother. 1991 Dec;35(12):2500–2504. doi: 10.1128/aac.35.12.2500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bannerman T. L., Wadiak D. L., Kloos W. E. Susceptibility of Staphylococcus species and subspecies to teicoplanin. Antimicrob Agents Chemother. 1991 Sep;35(9):1919–1922. doi: 10.1128/aac.35.9.1919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Benson C. A., Segreti J., Beaudette F. E., Hines D. W., Goodman L. J., Kaplan R. L., Trenholme G. M. In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. Antimicrob Agents Chemother. 1987 Feb;31(2):328–330. doi: 10.1128/aac.31.2.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Berry A. J., Johnston J. L., Archer G. L. Imipenem therapy of experimental Staphylococcus epidermidis endocarditis. Antimicrob Agents Chemother. 1986 May;29(5):748–752. doi: 10.1128/aac.29.5.748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Biavasco F., Giovanetti E., Montanari M. P., Lupidi R., Varaldo P. E. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species. J Antimicrob Chemother. 1991 Jan;27(1):71–79. doi: 10.1093/jac/27.1.71. [DOI] [PubMed] [Google Scholar]
  15. Bismuth R., Zilhao R., Sakamoto H., Guesdon J. L., Courvalin P. Gene heterogeneity for tetracycline resistance in Staphylococcus spp. Antimicrob Agents Chemother. 1990 Aug;34(8):1611–1614. doi: 10.1128/aac.34.8.1611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Byrne M. E., Gillespie M. T., Skurray R. A. 4',4'' adenyltransferase activity on conjugative plasmids isolated from Staphylococcus aureus is encoded on an integrated copy of pUB110. Plasmid. 1991 Jan;25(1):70–75. doi: 10.1016/0147-619x(91)90008-k. [DOI] [PubMed] [Google Scholar]
  17. Byrne M. E., Gillespie M. T., Skurray R. A. Molecular analysis of a gentamicin resistance transposonlike element on plasmids isolated from North American Staphylococcus aureus strains. Antimicrob Agents Chemother. 1990 Nov;34(11):2106–2113. doi: 10.1128/aac.34.11.2106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Chambers H. F. Methicillin-resistant staphylococci. Clin Microbiol Rev. 1988 Apr;1(2):173–186. doi: 10.1128/cmr.1.2.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Coudron P. E., Jones D. L., Dalton H. P., Archer G. L. Evaluation of laboratory tests for detection of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. J Clin Microbiol. 1986 Nov;24(5):764–769. doi: 10.1128/jcm.24.5.764-769.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Coughter J. P., Johnston J. L., Archer G. L. Characterization of a staphylococcal trimethoprim resistance gene and its product. Antimicrob Agents Chemother. 1987 Jul;31(7):1027–1032. doi: 10.1128/aac.31.7.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Dryden M. S., Talsania H., McCann M., Cookson B. D., Phillips I. The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients. Epidemiol Infect. 1992 Aug;109(1):97–112. [PMC free article] [PubMed] [Google Scholar]
  22. Eady E. A., Ross J. I., Tipper J. L., Walters C. E., Cove J. H., Noble W. C. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother. 1993 Feb;31(2):211–217. doi: 10.1093/jac/31.2.211. [DOI] [PubMed] [Google Scholar]
  23. Eliopoulos G. M., Wennersten C. B., Cole G., Moellering R. C. In vitro activities of two glycylcyclines against gram-positive bacteria. Antimicrob Agents Chemother. 1994 Mar;38(3):534–541. doi: 10.1128/aac.38.3.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Fass R. J. In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci. Antimicrob Agents Chemother. 1991 Mar;35(3):553–559. doi: 10.1128/aac.35.3.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Forbes B. A., Schaberg D. R. Transfer of resistance plasmids from Staphylococcus epidermidis to Staphylococcus aureus: evidence for conjugative exchange of resistance. J Bacteriol. 1983 Feb;153(2):627–634. doi: 10.1128/jb.153.2.627-634.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Froggatt J. W., Johnston J. L., Galetto D. W., Archer G. L. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob Agents Chemother. 1989 Apr;33(4):460–466. doi: 10.1128/aac.33.4.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Galetto D. W., Johnston J. L., Archer G. L. Molecular epidemiology of trimethoprim resistance among coagulase-negative staphylococci. Antimicrob Agents Chemother. 1987 Nov;31(11):1683–1688. doi: 10.1128/aac.31.11.1683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. George R. C., Ball L. C., Norbury P. B. Susceptibility to ciprofloxacin of nosocomial gram-negative bacteria and staphylococci isolated in the UK. J Antimicrob Chemother. 1990 Dec;26 (Suppl F):145–156. doi: 10.1093/jac/26.suppl_f.145. [DOI] [PubMed] [Google Scholar]
  29. Goldstein F. W., Coutrot A., Sieffer A., Acar J. F. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother. 1990 May;34(5):899–900. doi: 10.1128/aac.34.5.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hamilton-Miller J. M. In-vitro activities of 14-, 15- and 16-membered macrolides against gram-positive cocci. J Antimicrob Chemother. 1992 Feb;29(2):141–147. doi: 10.1093/jac/29.2.141. [DOI] [PubMed] [Google Scholar]
  31. Herwaldt L., Boyken L., Pfaller M. In vitro selection of resistance to vancomycin in bloodstream isolates of Staphylococcus haemolyticus and Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis. 1991 Dec;10(12):1007–1012. doi: 10.1007/BF01984921. [DOI] [PubMed] [Google Scholar]
  32. Hope P. G., Kristinsson K. G., Norman P., Elson R. A. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br. 1989 Nov;71(5):851–855. doi: 10.1302/0301-620X.71B5.2584258. [DOI] [PubMed] [Google Scholar]
  33. Hori S., Ohshita Y., Utsui Y., Hiramatsu K. Sequential acquisition of norfloxacin and ofloxacin resistance by methicillin-resistant and -susceptible Staphylococcus aureus. Antimicrob Agents Chemother. 1993 Nov;37(11):2278–2284. doi: 10.1128/aac.37.11.2278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Huband M. D., Cohen M. A., Meservey M. A., Roland G. E., Yoder S. L., Dazer M. E., Domagala J. M. In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency. Antimicrob Agents Chemother. 1993 Dec;37(12):2563–2570. doi: 10.1128/aac.37.12.2563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Jones R. N., Barry A. L., Gardiner R. V., Packer R. R. The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers. Diagn Microbiol Infect Dis. 1989 Sep-Oct;12(5):385–394. doi: 10.1016/0732-8893(89)90108-9. [DOI] [PubMed] [Google Scholar]
  36. Karchmer A. W., Archer G. L., Dismukes W. E. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med. 1983 Apr;98(4):447–455. doi: 10.7326/0003-4819-98-4-447. [DOI] [PubMed] [Google Scholar]
  37. Kloos W. E., Bannerman T. L. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev. 1994 Jan;7(1):117–140. doi: 10.1128/cmr.7.1.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Korten V., Tomayko J. F., Murray B. E. Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci. Antimicrob Agents Chemother. 1994 Mar;38(3):611–615. doi: 10.1128/aac.38.3.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Kotilainen P., Nikoskelainen J., Huovinen P. Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. J Infect Dis. 1990 Jan;161(1):41–44. doi: 10.1093/infdis/161.1.41. [DOI] [PubMed] [Google Scholar]
  40. Levitz R. E., Quintiliani R. Trimethoprim-sulfamethoxazole for bacterial meningitis. Ann Intern Med. 1984 Jun;100(6):881–890. doi: 10.7326/0003-4819-100-6-881. [DOI] [PubMed] [Google Scholar]
  41. Loncle V., Casetta A., Buu-Hoi A., el Solh N. Analysis of pristinamycin-resistant Staphylococcus epidermidis isolates responsible for an outbreak in a Parisian hospital. Antimicrob Agents Chemother. 1993 Oct;37(10):2159–2165. doi: 10.1128/aac.37.10.2159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Lyon B. R., May J. W., Skurray R. A. Analysis of plasmids in nosocomial strains of multiple-antibiotic-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1983 Jun;23(6):817–826. doi: 10.1128/aac.23.6.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Lyon B. R., May J. W., Skurray R. A. Tn4001: a gentamicin and kanamycin resistance transposon in Staphylococcus aureus. Mol Gen Genet. 1984;193(3):554–556. doi: 10.1007/BF00382099. [DOI] [PubMed] [Google Scholar]
  44. Markowitz N., Quinn E. L., Saravolatz L. D. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med. 1992 Sep 1;117(5):390–398. doi: 10.7326/0003-4819-117-5-390. [DOI] [PubMed] [Google Scholar]
  45. Maskell J. P., Sefton A. M., Williams J. D. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes. J Antimicrob Chemother. 1990 Jan;25 (Suppl A):19–24. doi: 10.1093/jac/25.suppl_a.19. [DOI] [PubMed] [Google Scholar]
  46. Maugein J., Pellegrin J. L., Brossard G., Fourche J., Leng B., Reiffers J. In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients. Antimicrob Agents Chemother. 1990 May;34(5):901–903. doi: 10.1128/aac.34.5.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. McDonnell R. W., Sweeney H. M., Cohen S. Conjugational transfer of gentamicin resistance plasmids intra- and interspecifically in Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 1983 Jan;23(1):151–160. doi: 10.1128/aac.23.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Nightingale S. D., Cameron D. W., Gordin F. M., Sullam P. M., Cohn D. L., Chaisson R. E., Eron L. J., Sparti P. D., Bihari B., Kaufman D. L. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med. 1993 Sep 16;329(12):828–833. doi: 10.1056/NEJM199309163291202. [DOI] [PubMed] [Google Scholar]
  49. Oppenheim B. A., Hartley J. W., Lee W., Burnie J. P. Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit. BMJ. 1989 Jul 29;299(6694):294–297. doi: 10.1136/bmj.299.6694.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Piddock L. J. New quinolones and gram-positive bacteria. Antimicrob Agents Chemother. 1994 Feb;38(2):163–169. doi: 10.1128/aac.38.2.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Ross J. I., Eady E. A., Cove J. H., Cunliffe W. J., Baumberg S., Wootton J. C. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol. 1990 Jul;4(7):1207–1214. doi: 10.1111/j.1365-2958.1990.tb00696.x. [DOI] [PubMed] [Google Scholar]
  52. Rouch D. A., Messerotti L. J., Loo L. S., Jackson C. A., Skurray R. A. Trimethoprim resistance transposon Tn4003 from Staphylococcus aureus encodes genes for a dihydrofolate reductase and thymidylate synthetase flanked by three copies of IS257. Mol Microbiol. 1989 Feb;3(2):161–175. doi: 10.1111/j.1365-2958.1989.tb01805.x. [DOI] [PubMed] [Google Scholar]
  53. Ryffel C., Tesch W., Birch-Machin I., Reynolds P. E., Barberis-Maino L., Kayser F. H., Berger-Bächi B. Sequence comparison of mecA genes isolated from methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Gene. 1990 Sep 28;94(1):137–138. doi: 10.1016/0378-1119(90)90481-6. [DOI] [PubMed] [Google Scholar]
  54. Schwalbe R. S., Ritz W. J., Verma P. R., Barranco E. A., Gilligan P. H. Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J Infect Dis. 1990 Jan;161(1):45–51. doi: 10.1093/infdis/161.1.45. [DOI] [PubMed] [Google Scholar]
  55. Schwalbe R. S., Stapleton J. T., Gilligan P. H. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 1987 Apr 9;316(15):927–931. doi: 10.1056/NEJM198704093161507. [DOI] [PubMed] [Google Scholar]
  56. Segreti J., Gvazdinskas L. C., Trenholme G. M. In vitro activity of minocycline and rifampin against staphylococci. Diagn Microbiol Infect Dis. 1989 May-Jun;12(3):253–255. doi: 10.1016/0732-8893(89)90022-9. [DOI] [PubMed] [Google Scholar]
  57. Soussy C. J., Bouanchaud D. H., Fouace J., Dublanchet A., Duval J. A gentamycin resistance plasmid in Staphylococcus aureus. Ann Microbiol (Paris) 1975 Jul-Aug;126B(1):91–94. [PubMed] [Google Scholar]
  58. Sreedharan S., Peterson L. R., Fisher L. M. Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 1991 Oct;35(10):2151–2154. doi: 10.1128/aac.35.10.2151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Testa R. T., Petersen P. J., Jacobus N. V., Sum P. E., Lee V. J., Tally F. P. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Antimicrob Agents Chemother. 1993 Nov;37(11):2270–2277. doi: 10.1128/aac.37.11.2270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Thakker-Varia S., Jenssen W. D., Moon-McDermott L., Weinstein M. P., Dubin D. T. Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob Agents Chemother. 1987 May;31(5):735–743. doi: 10.1128/aac.31.5.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Thomas W. D., Jr, Archer G. L. Mobility of gentamicin resistance genes from staphylococci isolated in the United States: identification of Tn4031, a gentamicin resistance transposon from Staphylococcus epidermidis. Antimicrob Agents Chemother. 1989 Aug;33(8):1335–1341. doi: 10.1128/aac.33.8.1335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Thomson K. S., Sanders C. C., Hayden M. E. In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises. Antimicrob Agents Chemother. 1991 Nov;35(11):2329–2334. doi: 10.1128/aac.35.11.2329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Thornsberry C., Hill B. C., Swenson J. M., McDougal L. K. Rifampin: spectrum of antibacterial activity. Rev Infect Dis. 1983 Jul-Aug;5 (Suppl 3):S412–S417. doi: 10.1093/clinids/5.supplement_3.s412. [DOI] [PubMed] [Google Scholar]
  64. Trimethoprim resistance; epidemiology and molecular aspects. J Med Microbiol. 1990 Jan;31(1):1–19. doi: 10.1099/00222615-31-1-1. [DOI] [PubMed] [Google Scholar]
  65. Trucksis M., Wolfson J. S., Hooper D. C. A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus. J Bacteriol. 1991 Sep;173(18):5854–5860. doi: 10.1128/jb.173.18.5854-5860.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Ubukata K., Nakagami S., Nitta A., Yamane A., Kawakami S., Sugiura M., Konno M. Rapid detection of the mecA gene in methicillin-resistant staphylococci by enzymatic detection of polymerase chain reaction products. J Clin Microbiol. 1992 Jul;30(7):1728–1733. doi: 10.1128/jcm.30.7.1728-1733.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Ubukata K., Nonoguchi R., Matsuhashi M., Song M. D., Konno M. Restriction maps of the regions coding for methicillin and tobramycin resistances on chromosomal DNA in methicillin-resistant staphylococci. Antimicrob Agents Chemother. 1989 Sep;33(9):1624–1626. doi: 10.1128/aac.33.9.1624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Unal S., Hoskins J., Flokowitsch J. E., Wu C. Y., Preston D. A., Skatrud P. L. Detection of methicillin-resistant staphylococci by using the polymerase chain reaction. J Clin Microbiol. 1992 Jul;30(7):1685–1691. doi: 10.1128/jcm.30.7.1685-1691.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Vazquez G. J., Archer G. L. Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis. Antimicrob Agents Chemother. 1980 Feb;17(2):280–285. doi: 10.1128/aac.17.2.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Veach L. A., Pfaller M. A., Barrett M., Koontz F. P., Wenzel R. P. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol. 1990 Sep;28(9):2064–2068. doi: 10.1128/jcm.28.9.2064-2068.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Weisblum B. Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression--a review. J Antimicrob Chemother. 1985 Jul;16 (Suppl A):63–90. doi: 10.1093/jac/16.suppl_a.63. [DOI] [PubMed] [Google Scholar]
  72. Wolfson J. S., Hooper D. C. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother. 1985 Oct;28(4):581–586. doi: 10.1128/aac.28.4.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Yamamoto T., Takubo S., Fujita K., Oguri T., Yokota T. Cloning and restriction analysis of DNA conferring new quinolone antimicrobial agent resistance from Staphylococcus aureus and other coagulase-negative Staphylococcus species. FEMS Microbiol Lett. 1990 Mar 15;56(3):335–339. doi: 10.1111/j.1574-6968.1990.tb13961.x. [DOI] [PubMed] [Google Scholar]
  74. Zinner S. H., Lagast H., Klastersky J. Antistaphylococcal activity of rifampin with other antibiotics. J Infect Dis. 1981 Oct;144(4):365–371. doi: 10.1093/infdis/144.4.365. [DOI] [PubMed] [Google Scholar]
  75. el Solh N., Moreau N., Ehrlich S. D. Molecular cloning and analysis of Staphylococcus aureus chromosomal aminoglycoside resistance genes. Plasmid. 1986 Mar;15(2):104–118. doi: 10.1016/0147-619x(86)90047-8. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES